Catamaran Bio Overview
- Year Founded
-
2020
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
7
Catamaran Bio General Information
Description
Developer of allogeneic immune cell therapies designed to provide treatments for solid tumors and other cancers. The company engages in using genetic engineering of natural killer cells to target several therapeutic areas with high unmet needs, enabling medical practitioners and individuals to procure therapies for treating conditions.
Contact Information
Website
www.catamaranbio.comCorporate Office
- 451 D Street
- Boston, MA 02210
- United States
Corporate Office
- 451 D Street
- Boston, MA 02210
- United States
Catamaran Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 2. Early Stage VC (Series A) | 23-Nov-2020 | Completed | Generating Revenue | |||
| 1. University Spin-Out | 01-Jan-2020 | Completed | Startup |
Catamaran Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Series A2 | ||||||||
| Series A1 | 54,285,708 | $0.000100 | 8% | $0.7 | $0.7 | 1x | $0.7 | 0% |
Catamaran Bio Comparisons
Industry
Financing
Details
Catamaran Bio Competitors (2)
One of Catamaran Bio’s 2 competitors is Dragonfly (Drug Discovery), a Venture Capital-Backed company based in Waltham, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Dragonfly (Drug Discovery) | Venture Capital-Backed | Waltham, MA | ||||
| Nkarta Therapeutics | Formerly VC-backed | South San Francisco, CA |
Catamaran Bio Patents
Catamaran Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240156867-A1 | Engineered immune cell therapeutics and methods of use | Pending | 11-Nov-2022 | ||
| WO-2023172514-A1 | Engineered immune cell therapeutics targeted to her2 and methods of use thereof | Inactive | 07-Mar-2022 | ||
| AU-2021388155-A1 | Cellular therapeutics engineered with signal modulators and methods of use thereof | Pending | 25-Nov-2020 | ||
| EP-4251645-A1 | Cellular therapeutics engineered with signal modulators and methods of use thereof | Pending | 25-Nov-2020 | ||
| US-20220162288-A1 | Cellular therapeutics engineered with signal modulators and methods of use thereof | Inactive | 25-Nov-2020 | C07K14/70503 |
Catamaran Bio Signals
Catamaran Bio Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Astellas Venture Management | Corporate Venture Capital | Minority | ||
| Lightstone Ventures | Venture Capital | Minority | ||
| Sofinnova Partners | Venture Capital | Minority | ||
| SV Health Investors | PE/Buyout | Minority | ||
| Takeda Ventures | Corporate Venture Capital | Minority |
Catamaran Bio FAQs
-
When was Catamaran Bio founded?
Catamaran Bio was founded in 2020.
-
Where is Catamaran Bio headquartered?
Catamaran Bio is headquartered in Boston, MA.
-
What is the size of Catamaran Bio?
Catamaran Bio has 14 total employees.
-
What industry is Catamaran Bio in?
Catamaran Bio’s primary industry is Drug Discovery.
-
Is Catamaran Bio a private or public company?
Catamaran Bio is a Private company.
-
What is Catamaran Bio’s current revenue?
The current revenue for Catamaran Bio is .
-
How much funding has Catamaran Bio raised over time?
Catamaran Bio has raised $42M.
-
Who are Catamaran Bio’s investors?
Astellas Venture Management, Lightstone Ventures, Sofinnova Partners, SV Health Investors, and Takeda Ventures are 5 of 7 investors who have invested in Catamaran Bio.
-
Who are Catamaran Bio’s competitors?
Dragonfly (Drug Discovery) and Nkarta Therapeutics are competitors of Catamaran Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process